Click Here to
News, Updates,
& More
Stay Up
to Date

Pancreatic Cancer

A claims analysis of elderly patients with pancreatic cancer has shown that those receiving early palliative care consultations had lower healthcare utilization, including emergency department-related costs, than patients who received late palliative care.
By improving chemotherapy-induced peripheral neuropathy (CIPN), administration of duloxetine may enable patients with advanced pancreatic cancer to continue their treatment regimen of gemcitabine plus nab-paclitaxel.

Results 1 - 2 of 2